These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26299988)

  • 21. Impact of age and heterophilic interference on the basal serum tryptase, a risk indication for anaphylaxis, in 1,092 dermatology patients.
    Schliemann S; Seyfarth F; Hipler UC; Elsner P
    Acta Derm Venereol; 2012 Sep; 92(5):484-9. PubMed ID: 22170044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of vaccination safety in children with mastocytosis.
    Parente R; Pucino V; Magliacane D; Petraroli A; Loffredo S; Marone G; Triggiani M
    Pediatr Allergy Immunol; 2017 Feb; 28(1):93-95. PubMed ID: 27590431
    [No Abstract]   [Full Text] [Related]  

  • 23. Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis.
    Wiechers T; Rabenhorst A; Schick T; Preussner LM; Förster A; Valent P; Horny HP; Sotlar K; Hartmann K
    J Allergy Clin Immunol; 2015 Dec; 136(6):1581-1590.e3. PubMed ID: 26152315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
    Kim S; Kim MY; Koh J; Go H; Lee DS; Jeon YK; Chung DH
    Eur J Cancer; 2015 Nov; 51(17):2698-707. PubMed ID: 26329973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
    Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
    Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric mastocytosis: routine anesthetic management for a complex disease.
    Carter MC; Uzzaman A; Scott LM; Metcalfe DD; Quezado Z
    Anesth Analg; 2008 Aug; 107(2):422-7. PubMed ID: 18633019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers.
    Aoki T; Hino M; Koh K; Kyushiki M; Kishimoto H; Arakawa Y; Hanada R; Kawashima H; Kurihara J; Shimojo N; Motohashi S
    Pediatr Blood Cancer; 2016 Aug; 63(8):1461-4. PubMed ID: 27135656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How much specific is the association between hymenoptera venom allergy and mastocytosis?
    Bonadonna P; Zanotti R; Pagani M; Caruso B; Perbellini O; Colarossi S; Olivieri E; Dama A; Schiappoli M; Senna G; Antico A; Passalacqua G
    Allergy; 2009 Sep; 64(9):1379-82. PubMed ID: 19627274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug allergy in mastocytosis.
    Bonadonna P; Lombardo C
    Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated baseline serum tryptase, mastocytosis and anaphylaxis.
    Müller UR
    Clin Exp Allergy; 2009 May; 39(5):620-2. PubMed ID: 19400907
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
    Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
    Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):47S-51S. PubMed ID: 2002263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP.
    Zhong J; Chen S; Xu L; Lai J; Liao Z; Zhang T; Yu Z; Lu Y; Yang L; Wu X; Li B; Li Y
    Hematology; 2016 Oct; 21(9):552-7. PubMed ID: 27077771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of PD-L1 in mastocytosis.
    Kuklinski LF; Kim J
    J Am Acad Dermatol; 2016 May; 74(5):1010-2. PubMed ID: 27085232
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
    Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
    Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical aspects of paediatric mastocytosis: a review of 101 cases.
    Lange M; Niedoszytko M; Renke J; Gleń J; Nedoszytko B
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):97-102. PubMed ID: 22126331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.
    Sánchez-Muñoz L; Morgado JM; Álvarez-Twose I; Matito A; Garcia-Montero AC; Teodosio C; Jara-Acevedo M; Mayado A; Mollejo M; Caldas C; González de Olano D; Escribano L; Orfao A
    Br J Haematol; 2016 Jan; 172(1):56-63. PubMed ID: 26456532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.